176 related articles for article (PubMed ID: 22939663)
21. Viral load response to a pneumococcal conjugate vaccine, polysaccharide vaccine or placebo among HIV-infected patients.
Goetz MB; Feikin DR; Lennox JL; O'Brien WA; Elie CM; Butler JC; Breiman RF
AIDS; 2002 Jul; 16(10):1421-3. PubMed ID: 12131220
[TBL] [Abstract][Full Text] [Related]
22. Alterations in serotype-specific B cell responses to the 13-valent pneumococcal conjugate vaccine in aging HIV-infected adults.
Ohtola JA; Khaskhely NM; Saul-Mcbeth JL; Iyer AS; Leggat DJ; Khuder SA; Westerink MAJ
Vaccine; 2016 Jan; 34(4):451-457. PubMed ID: 26707220
[TBL] [Abstract][Full Text] [Related]
23. Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults.
Lesprit P; Pédrono G; Molina JM; Goujard C; Girard PM; Sarrazin N; Katlama C; Yéni P; Morineau P; Delfraissy JF; Chêne G; Lévy Y;
AIDS; 2007 Nov; 21(18):2425-34. PubMed ID: 18025879
[TBL] [Abstract][Full Text] [Related]
24. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
25. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
26. Induction of immunologic memory following primary vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in infants.
Knuf M; Pankow-Culot H; Grunert D; Rapp M; Panzer F; Köllges R; Fanic A; Habib A; Borys D; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2012 Jan; 31(1):e31-6. PubMed ID: 21909049
[TBL] [Abstract][Full Text] [Related]
27. Viro-immunological outcomes after 13-valent pneumococcal vaccination in HIV-1-infected individuals on stable virological suppression.
Dell'Acqua R; Galli L; Poli A; Mastrangelo A; Guffanti M; Tadini P; Zandona D; Danise A; Gianotti N; Lazzarin A; Castagna A; Nozza S
AIDS; 2019 Nov; 33(13):1987-1994. PubMed ID: 31306174
[TBL] [Abstract][Full Text] [Related]
28. Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users.
Amendola A; Tanzi E; Zappa A; Colzani D; Boschini A; Musher DM; Zanetti AR
Vaccine; 2002 Nov; 20(31-32):3720-4. PubMed ID: 12399200
[TBL] [Abstract][Full Text] [Related]
29. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
30. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
31. A therapeutic HIV-1 vaccine enhances anti-HIV-1 immune responses in patients under highly active antiretroviral therapy.
Tung FY; Tung JK; Pallikkuth S; Pahwa S; Fischl MA
Vaccine; 2016 Apr; 34(19):2225-32. PubMed ID: 27002500
[TBL] [Abstract][Full Text] [Related]
32. Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy.
Madhi SA; Cohen C; von Gottberg A
Vaccine; 2012 Sep; 30 Suppl 3():C21-7. PubMed ID: 22939016
[TBL] [Abstract][Full Text] [Related]
33. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity and Immunological Memory Induced by the 13-Valent Pneumococcal Conjugate Followed by the 23-Valent Polysaccharide Vaccine in HIV-Infected Adults.
Farmaki PF; Chini MC; Mangafas NM; Tzanoudaki MT; Piperi CP; Lazanas MZ; Spoulou VS
J Infect Dis; 2018 Jun; 218(1):26-34. PubMed ID: 29722823
[TBL] [Abstract][Full Text] [Related]
35. Long-term immune responses and comparative effectiveness of one or two doses of 7-valent pneumococcal conjugate vaccine (PCV7) in HIV-positive adults in the era of combination antiretroviral therapy.
Cheng A; Chang SY; Tsai MS; Su YC; Liu WC; Sun HY; Hung CC
J Int AIDS Soc; 2016; 19(1):20631. PubMed ID: 26829360
[TBL] [Abstract][Full Text] [Related]
36. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
[TBL] [Abstract][Full Text] [Related]
37. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
[TBL] [Abstract][Full Text] [Related]
38. Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults.
Kroon FP; van Dissel JT; Ravensbergen E; Nibbering PH; van Furth R
Vaccine; 2000 Nov; 19(7-8):886-94. PubMed ID: 11115712
[TBL] [Abstract][Full Text] [Related]
39. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
Viani RM; Araneta MR; Deville JG; Spector SA
Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
[TBL] [Abstract][Full Text] [Related]
40. Immunization against pneumococcal disease in HIV-infected patients: conjugate versus polysaccharide vaccine before or after reconstitution of the immune system (CTN-147).
Slayter KL; Singer J; Lee TC; Kayhty H; Schlech WF
Int J STD AIDS; 2013 Mar; 24(3):227-31. PubMed ID: 23535358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
